US2010255132A1PendingUtilityA1

Novel botanical formulation for treating sickle cell disease

Assignee: NATHAN SWAMIPriority: Apr 6, 2009Filed: Apr 6, 2010Published: Oct 7, 2010
Est. expiryApr 6, 2029(~2.7 yrs left)· nominal 20-yr term from priority
A61P 7/06A61P 7/00A61K 36/899
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An improved plant medicament composition, comprising an extract of Sorghum bicolor plant material for treating sickle cell disease is described. A method for the preparation of said composition having the property of inhibiting sickle cells is also provided.

Claims

exact text as granted — not AI-modified
1 . A botanical composition for inhibiting sickling in sickle cell disease, comprising an extraction from  Sorghum bicolor  plant material, without using material from any other plant, said extraction being effective against sickle cells. 
     
     
         2 . The composition of  claim 1  further comprising any pharmaceutically acceptable carrier and excipients. 
     
     
         3 . The composition of  claim 2 , wherein said extraction is formulated as a solution, suspension, powder, tablet or capsule. 
     
     
         4 . A method for preparing a botanical composition, comprising the steps of:
 (i) obtaining an extract having anti-sickling activity from  Sorgum bicolor  plant material; and   (ii) preparing said extract in a suitable form for treating sickle cells.   
     
     
         5 . The method of  claim 4 , comprising the steps of:
 (i) extracting  Sorghum bicolor  plant material with a 7.4% weight by volume aqueous solution of sodium bicarbonate at a pH ranging from about 8.0 to about 8.3 by stirring for about 8 hr at normal ambient temperature;   (ii) allowing the extract to settle, then decanting, filtering, centrifuging and freeze drying the resulting material; and   (iii) thoroughly blending the freeze dried material to form a uniform mixture.   
     
     
         6 . The method of  claim 5 , further comprising any pharmaceutically acceptable carrier and excipients. 
     
     
         7 . The method of  claim 6 , administering said blended uniform mixture for treating sickle cell disease in a powder, tablet, capsule, granular or suspension form.

Join the waitlist — get patent alerts

Track US2010255132A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.